Logo image of SRE

SEMPRA (SRE) Stock Fundamental Analysis

USA - NYSE:SRE - US8168511090 - Common Stock

92.29 USD
-0.43 (-0.46%)
Last: 10/21/2025, 8:04:00 PM
92.29 USD
0 (0%)
After Hours: 10/21/2025, 8:04:00 PM
Fundamental Rating

2

Overall SRE gets a fundamental rating of 2 out of 10. We evaluated SRE against 25 industry peers in the Multi-Utilities industry. SRE has a medium profitability rating, but doesn't score so well on its financial health evaluation. SRE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SRE was profitable.
In the past year SRE had a positive cash flow from operations.
Each year in the past 5 years SRE has been profitable.
In the past 5 years SRE always reported a positive cash flow from operatings.
SRE Yearly Net Income VS EBIT VS OCF VS FCFSRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B

1.2 Ratios

SRE's Return On Assets of 2.67% is on the low side compared to the rest of the industry. SRE is outperformed by 60.00% of its industry peers.
With a Return On Equity value of 8.42%, SRE is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
SRE has a worse Return On Invested Capital (2.77%) than 96.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SRE is in line with the industry average of 3.82%.
Industry RankSector Rank
ROA 2.67%
ROE 8.42%
ROIC 2.77%
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
SRE Yearly ROA, ROE, ROICSRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With an excellent Profit Margin value of 20.02%, SRE belongs to the best of the industry, outperforming 96.00% of the companies in the same industry.
In the last couple of years the Profit Margin of SRE has grown nicely.
The Operating Margin of SRE (22.76%) is better than 68.00% of its industry peers.
In the last couple of years the Operating Margin of SRE has declined.
Industry RankSector Rank
OM 22.76%
PM (TTM) 20.02%
GM N/A
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
SRE Yearly Profit, Operating, Gross MarginsSRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SRE is destroying value.
The number of shares outstanding for SRE has been increased compared to 1 year ago.
The number of shares outstanding for SRE has been increased compared to 5 years ago.
The debt/assets ratio for SRE is higher compared to a year ago.
SRE Yearly Shares OutstandingSRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SRE Yearly Total Debt VS Total AssetsSRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

SRE has an Altman-Z score of 0.96. This is a bad value and indicates that SRE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.96, SRE is in the better half of the industry, outperforming 72.00% of the companies in the same industry.
A Debt/Equity ratio of 1.17 is on the high side and indicates that SRE has dependencies on debt financing.
With a decent Debt to Equity ratio value of 1.17, SRE is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF N/A
Altman-Z 0.96
ROIC/WACC0.42
WACC6.65%
SRE Yearly LT Debt VS Equity VS FCFSRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

SRE has a Current Ratio of 0.48. This is a bad value and indicates that SRE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SRE (0.48) is worse than 96.00% of its industry peers.
A Quick Ratio of 0.41 indicates that SRE may have some problems paying its short term obligations.
SRE has a Quick ratio of 0.41. This is amonst the worse of the industry: SRE underperforms 92.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.41
SRE Yearly Current Assets VS Current LiabilitesSRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.31% over the past year.
Measured over the past years, SRE shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.31% on average per year.
The Revenue has decreased by -1.04% in the past year.
SRE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.04% yearly.
EPS 1Y (TTM)6.31%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%0%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%-0.37%

3.2 Future

SRE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.98% yearly.
SRE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.87% yearly.
EPS Next Y-1.07%
EPS Next 2Y4.64%
EPS Next 3Y5.94%
EPS Next 5Y6.98%
Revenue Next Year-12.8%
Revenue Next 2Y-4.25%
Revenue Next 3Y-3.19%
Revenue Next 5Y-0.87%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SRE Yearly Revenue VS EstimatesSRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
SRE Yearly EPS VS EstimatesSRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.55, which indicates a rather expensive current valuation of SRE.
SRE's Price/Earnings ratio is a bit more expensive when compared to the industry. SRE is more expensive than 60.00% of the companies in the same industry.
SRE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.77.
SRE is valuated rather expensively with a Price/Forward Earnings ratio of 18.24.
64.00% of the companies in the same industry are cheaper than SRE, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.23. SRE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.55
Fwd PE 18.24
SRE Price Earnings VS Forward Price EarningsSRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

92.00% of the companies in the same industry are cheaper than SRE, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.31
SRE Per share dataSRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.64%
EPS Next 3Y5.94%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.83%, SRE has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.74, SRE's dividend is way lower than its industry peers. On top of this 80.00% of the companies listed in the same industry pay a better dividend than SRE!
Compared to an average S&P500 Dividend Yield of 2.36, SRE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.83%

5.2 History

The dividend of SRE decreases each year by -9.71%.
SRE has been paying a dividend for at least 10 years, so it has a reliable track record.
As SRE did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-9.71%
Div Incr Years7
Div Non Decr Years7
SRE Yearly Dividends per shareSRE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

59.51% of the earnings are spent on dividend by SRE. This is a bit on the high side, but may be sustainable.
DP59.51%
EPS Next 2Y4.64%
EPS Next 3Y5.94%
SRE Yearly Income VS Free CF VS DividendSRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B
SRE Dividend Payout.SRE Dividend Payout, showing the Payout Ratio.SRE Dividend Payout.PayoutRetained Earnings

SEMPRA

NYSE:SRE (10/21/2025, 8:04:00 PM)

After market: 92.29 0 (0%)

92.29

-0.43 (-0.46%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners91.76%
Inst Owner Change-0.18%
Ins Owners0.04%
Ins Owner Change-7.4%
Market Cap60.22B
Analysts71.25
Price Target87.3 (-5.41%)
Short Float %1.85%
Short Ratio3.02
Dividend
Industry RankSector Rank
Dividend Yield 2.83%
Yearly Dividend2.41
Dividend Growth(5Y)-9.71%
DP59.51%
Div Incr Years7
Div Non Decr Years7
Ex-Date10-01 2025-10-01 (0.645)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.09%
Min EPS beat(2)4.16%
Max EPS beat(2)8.03%
EPS beat(4)2
Avg EPS beat(4)-2.82%
Min EPS beat(4)-16.27%
Max EPS beat(4)8.03%
EPS beat(8)4
Avg EPS beat(8)-1.5%
EPS beat(12)8
Avg EPS beat(12)1.82%
EPS beat(16)11
Avg EPS beat(16)2.7%
Revenue beat(2)0
Avg Revenue beat(2)-3.99%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)-3.89%
Revenue beat(4)0
Avg Revenue beat(4)-11.25%
Min Revenue beat(4)-22.35%
Max Revenue beat(4)-3.89%
Revenue beat(8)0
Avg Revenue beat(8)-15%
Revenue beat(12)2
Avg Revenue beat(12)-5.44%
Revenue beat(16)6
Avg Revenue beat(16)-1.39%
PT rev (1m)2.37%
PT rev (3m)5.4%
EPS NQ rev (1m)1.76%
EPS NQ rev (3m)2.93%
EPS NY rev (1m)0.13%
EPS NY rev (3m)0.16%
Revenue NQ rev (1m)-3.25%
Revenue NQ rev (3m)-4.39%
Revenue NY rev (1m)-3.47%
Revenue NY rev (3m)-5.22%
Valuation
Industry RankSector Rank
PE 19.55
Fwd PE 18.24
P/S 4.52
P/FCF N/A
P/OCF 12.94
P/B 1.9
P/tB 2.02
EV/EBITDA 17.31
EPS(TTM)4.72
EY5.11%
EPS(NY)5.06
Fwd EY5.48%
FCF(TTM)-8.26
FCFYN/A
OCF(TTM)7.13
OCFY7.73%
SpS20.44
BVpS48.61
TBVpS45.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.67%
ROE 8.42%
ROCE 3.32%
ROIC 2.77%
ROICexc 2.78%
ROICexgc 2.83%
OM 22.76%
PM (TTM) 20.02%
GM N/A
FCFM N/A
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
ROICexc(3y)3.32%
ROICexc(5y)3.56%
ROICexgc(3y)3.41%
ROICexgc(5y)3.66%
ROCE(3y)3.99%
ROCE(5y)4.26%
ROICexcg growth 3Y-8.37%
ROICexcg growth 5Y-5.96%
ROICexc growth 3Y-8.1%
ROICexc growth 5Y-5.8%
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF N/A
Debt/EBITDA 6.68
Cap/Depr 396.53%
Cap/Sales 75.31%
Interest Coverage 2.3
Cash Conversion 83.55%
Profit Quality N/A
Current Ratio 0.48
Quick Ratio 0.41
Altman-Z 0.96
F-Score4
WACC6.65%
ROIC/WACC0.42
Cap/Depr(3y)359.34%
Cap/Depr(5y)353.45%
Cap/Sales(3y)54.96%
Cap/Sales(5y)53.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.31%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%0%
EPS Next Y-1.07%
EPS Next 2Y4.64%
EPS Next 3Y5.94%
EPS Next 5Y6.98%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%-0.37%
Revenue Next Year-12.8%
Revenue Next 2Y-4.25%
Revenue Next 3Y-3.19%
Revenue Next 5Y-0.87%
EBIT growth 1Y9.84%
EBIT growth 3Y1.29%
EBIT growth 5Y1.48%
EBIT Next Year58.5%
EBIT Next 3Y22.25%
EBIT Next 5Y12.63%
FCF growth 1Y-0.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y84.97%
OCF growth 3Y8.5%
OCF growth 5Y9.71%